D-0503-2026 Class II Ongoing

Recalled by Wells Pharma Of Houston LLC — Houston, TX

FDA drug recall D-0503-2026 was initiated by Wells Pharma Of Houston LLC on Apr 1, 2026 and is designated Class II. Reason for recall: cGMP deviations. The recall status is ongoing. Affected quantity: 4,030 IV Bags.

Recall details

Product Type
Drugs
Report Date
May 6, 2026
Initiation Date
Apr 1, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,030 IV Bags

Product description

fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02.

Reason for recall

cGMP deviations.

Distribution pattern

U.S. Nationwide.

Code information

120925202022769, Expiration Date 04/09/2026, 123125202022883, Expiration Date 05/05/2026, 123125202022884, Expiration Date 05/05/2026 011226202020057, Expiration Date 05/14/2026, 011226202020058, Expiration Date 05/14/2026, 011626202020110, Expiration Date 05/20/2026 012726202020156, Expiration Date 05/28/2026. 012726202020161, Expiration Date 05/28/2026 020226202020195, Expiration Date 06/04/2026 021826202020386, Expiration Date 06/20/2026 022026202020417, Expiration Date 06/24/2026 022026202020424 Expiration Date 06/24/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0503-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0503-2026. Report a data issue: hello@regdatalab.com.